Big Pharma News Com | Big Pharma News – Big Pharma Information

Clinical trials

02/06/2018 / By Lance D Johnson

FAKE MEDICINE: “Randomized” drug trial protocols are frequently altered by industry sponsors who selectively remove participants that get sick

When it comes to making and approving pharmaceutical drugs, the science and procedure behind the process is readily corruptible. It can be manipulated to fulfill the wishes of pharmaceutical companies. A team of researchers from the Nordic Cochrane Centre in Copenhagen has exposed widespread corruption in drug trial protocols. The research, first published in the Journal […]

12/20/2017 / By Isabelle Z.

No good reason for the opioid epidemic: Clinical trial showed no “significant difference” in pain relief for treating arm or leg pain using opioids vs non-opioids

There is a lot of finger-pointing going on when it comes to the cause of the opioid epidemic. The pharmaceutical companies making these drugs often get the bulk of the blame, with the doctors who prescribe them following closely behind in the culpability leaderboard. To be fair, some opioid addictions start out fairly innocently, with […]

08/24/2017 / By Tracey Watson

Vaccine makers rely on “statistical gimmicks” to obscure the truth about HPV vaccines harming children

It has been more than a decade since Gardasil, the first ever vaccine specifically intended to prevent cancer, was approved for use by the FDA. At the time, Gardasil was touted as a miracle shot that would prevent young girls from being infected with the human papillomavirus (HPV), which causes genital warts, as well as […]

03/29/2017 / By Mike Adams

FAKE SCIENCE on parade as exact opposite news headlines appear right next to each other, citing the exact same study

A breakthrough scientific study published in the Journal of the American Medical Association says that vitamin D supplements are totally useless at preventing cancer. Yet the exact same study also provides compelling evidence that vitamin D supplements are highly effective at preventing cancer, according to the study’s own authors. What’s going on here? Science Daily […]

12/28/2016 / By Ethan Huff

Big pharma: Eli Lilly stock erases 6 years of dividends after failed drug trial

What investors had hoped would build into yet another 2.68 percent dividend yield for pharmaceutical behemoth Eli Lilly has turned into a massive financial letdown after trials of solanezumab, a supposedly promising experimental drug for Alzheimer’s disease and other forms of dementia, showed less than favorable efficacy in the latest clinical trials. Reports indicate that […]

1 of 1